Body Vision Medical announces distribution agreements for Argentina, Bolivia, Paraguay, Uruguay and Mexico
Body Vision Medical, a leader in AI-driven, intraoperative imaging, announced its exclusive distribution agreements with DeLeC Científica Uruguaya S.A. for Argentina, Bolivia, Paraguay and Uruguay and with Bio Scan S.A. for Mexico. These strategic partnerships facilitate Body Vision’s aim to expand access to its cutting-edge LungVision™ real-time, intraoperative CT imaging system to key markets in Central and South America.
LungVision™ harnesses the power of artificial intelligence (AI) to seamlessly transform X-ray images acquired from any C-arm into real-time, intraoperative CT scans. This game-changing technology empowers bronchoscopists to visualize pulmonary lesions in real time during diagnostic bronchoscopy and seamlessly integrates into their existing workflow. By augmenting the accuracy and precision of lung nodule biopsies through image guidance, LungVision™ has the potential to enable earlier-stage cancer detection and improve lung cancer survival rates.
“As lung cancer screening guidelines evolve to encompass earlier and more inclusive lung cancer screening of high-risk individuals, the capacity of institutions and clinicians to perform diagnostic bronchoscopy is going to have to grow commensurately to handle the incremental volume,” states Jon Ulvestad, Vice President of Sales and Marketing Development for Body Vision Medical. “These new partnerships with Bio Scan and DeLeC are important strides toward making a solution like LungVision™ that can economically increase both lung nodule biopsy capacity and diagnostic accuracy available to markets that can really benefit from such a technology.”
Body Vision Medical aims to expand lung patient access to LungVision™ into 60 markets by 2025 and, with these most recent distributorship signings, has a distribution footprint in 36 countries around the world.
SOURCE: PRNewswire
